UB-VV410
/ Umoja Biopharma, IASO BIO
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
August 08, 2025
UB-VV410 in Subjects With Active Refractory Systemic Lupus Erythematosus or Lupus Nephritis
(clinicaltrials.gov)
- P1 | N=21 | Not yet recruiting | Sponsor: Nanjing IASO Biotechnology Co., Ltd.
New P1 trial • Glomerulonephritis • Immunology • Inflammatory Arthritis • Lupus • Lupus Nephritis • Nephrology • Systemic Lupus Erythematosus
1 to 1
Of
1
Go to page
1